InsidersTradesSigma
Browse the detailed record of transactions filed by Glenn Mario Saldanha, Executive. Officer active across 1 company, notably Glenmark Pharmaceuticals Limited. Aggregated, 4 reports have been recorded. History available since 9 June 2021. The latest transaction was disclosed on 24 September 2021 (Purchase). Regulator: SEBI (PIT + SAST). The full history is openly available.
4 of 4 declarations
Glenn Mario Saldanha is an executive at Glenmark Pharmaceuticals Limited, an international pharmaceutical company. In his role, he oversees operations and the company's strategic initiatives. Glenmark Pharmaceuticals is known for its innovations in medications and treatments, and Saldanha contributes to implementing strategies to strengthen the company's position in the global market.